OCUL
Ocular Therapeutix, IncCompany with tickers: OCUL
Market Cap
$2.16B
Shares Outstanding
218,960,358
CIK
1393434
CUSIP
67576A100
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jason Robins | Chief Financial Officer | Appointed | 2026-06-12 |